A Phase II Study of Carfilzomib in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma
Status:
Terminated
Trial end date:
2017-12-20
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if carfilzomib can help control relapsed
or refractory MCL. The safety of this drug will also be studied.